A comprehensive study of p53 protein

被引:25
作者
Patil, Manisha R. [1 ]
Bihari, Anand [2 ]
机构
[1] Vellore Inst Technol, Sch Informat Technol & Engn, Dept Comp Applicat, Vellore, Tamil Nadu, India
[2] Vellore Inst Technol, Sch Comp Sci & Engn, Dept Computat Intelligence, Vellore 632014, Tamil Nadu, India
关键词
angiogenesis; apoptosis; guardian of the genome; p53; protein; SV40 T antigen; tumor suppressor gene; WILD-TYPE P53; CELLULAR TUMOR-ANTIGEN; MURINE LEUKEMIA-VIRUS; DAMAGE-INDUCED PHOSPHORYLATION; TEMPERATURE-SENSITIVE MUTANT; HUMAN-PAPILLOMAVIRUS TYPE-16; GAIN-OF-FUNCTION; LARGE T-ANTIGEN; TRANSCRIPTIONAL ACTIVATION; DNA-DAMAGE;
D O I
10.1002/jcb.30331
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protein p53 has been extensively investigated since it was found 43 years ago and has become a "guardian of the genome" that regulates the division of cells by preventing the growth of cells and dividing them, that is, inhibits the development of tumors. Initial proof of protein existence by researchers in the mid-1970s was found by altering and regulating the SV40 big T antigen termed the A protein. Researchers demonstrated how viruses play a role in cancer by employing viruses' ability to create T-antigens complex with viral tumors, which was discovered in 1979 following a viral analysis and cancer analog research. Researchers later in the year 1989 explained that in Murine Friend, a virus-caused erythroleukemia, commonly found that p53 was inactivated to suggest that p53 could be a "tumor suppressor gene." The TP53 gene, encoding p53, is one of human cancer's most frequently altered genes. The protein-regulated biological functions of all p53s include cell cycles, apoptosis, senescence, metabolism of the DNA, angiogenesis, cell differentiation, and immunological response. We tried to unfold the history of the p53 protein, which was discovered long back in 1979, that is, 43 years of research on p53, and how p53's function has been developed through time in this article.
引用
收藏
页码:1891 / 1937
页数:47
相关论文
共 279 条
[1]  
Adetiba Emmanuel, 2015, ScientificWorldJournal, V2015, P786013, DOI 10.1155/2015/786013
[2]   P53 CONTROLS BOTH THE G(2)/M AND THE G(1) CELL-CYCLE CHECKPOINTS AND MEDIATES REVERSIBLE GROWTH ARREST IN HUMAN FIBROBLASTS [J].
AGARWAL, ML ;
AGARWAL, A ;
TAYLOR, WR ;
STARK, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8493-8497
[3]   ALTERATIONS IN THE P53 GENE AND THE CLONAL EVOLUTION OF THE BLAST CRISIS OF CHRONIC MYELOCYTIC-LEUKEMIA [J].
AHUJA, H ;
BARELI, M ;
ADVANI, SH ;
BENCHIMOL, S ;
CLINE, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6783-6787
[4]   The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer [J].
Almquist, Lindsay M. ;
Karagas, Margaret R. ;
Christensen, Brock C. ;
Welsh, Marleen M. ;
Perry, Ann E. ;
Storm, Craig A. ;
Nelson, Heather H. .
CARCINOGENESIS, 2011, 32 (03) :327-330
[5]  
Anderson CW., 1986, CANCER CELL, V4, P395
[6]   IMMUNOLOGICALLY DISTINCT P53 MOLECULES GENERATED BY ALTERNATIVE SPLICING [J].
ARAI, N ;
NOMURA, D ;
YOKOTA, K ;
WOLF, D ;
BRILL, E ;
SHOHAT, O ;
ROTTER, V .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (09) :3232-3239
[7]   How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? [J].
Aubrey, Brandon J. ;
Kelly, Gemma L. ;
Janic, Ana ;
Herold, Marco J. ;
Strasser, Andreas .
CELL DEATH AND DIFFERENTIATION, 2018, 25 (01) :104-113
[8]   New plays in the p53 theater [J].
Aylon, Yael ;
Oren, Moshe .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2011, 21 (01) :86-92
[9]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[10]  
BAKER SJ, 1990, CANCER RES, V50, P7717